Hepcidin mutation in a β-thalassemia major patient with persistent severe iron overload despite chelation therapy

被引：0
|
作者：
Lorena Duca
Paola Delbini
Isabella Nava
Maria Domenica Cappellini
Anna Meo
机构：
[1] University of Milan,Department of Internal Medicine, Maggiore Policlinico, Mangiagalli and Regina Elena Foundation IRCCS
[2] University of Messina,Department of Pediatrics “G.Martino” Policlinico, Faculty of Medicine
来源：
Internal and Emergency Medicine | 2010年 / 5卷
关键词：
Iron Overload; Thalassemia; Chelation Therapy; Liver Iron Concentration; Hepcidin Expression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：83 / 85
页数：2
相关论文
共 50 条
  • [1] Hepcidin mutation in a β-thalassemia major patient with persistent severe iron overload despite chelation therapy
    Duca, Lorena
    Delbini, Paola
    Nava, Isabella
    Cappellini, Maria Domenica
    Meo, Anna
    INTERNAL AND EMERGENCY MEDICINE, 2010, 5 (01) : 83 - 85
  • [2] Efficacy and safety of combined oral iron chelation therapy with deferasirox and deferiprone in a patient with beta-thalassemia major and persistent iron overload
    Alavi, Samin
    Sadeghi, Elham
    Ashenagar, Azin
    BLOOD RESEARCH, 2014, 49 (01) : 72 - 73
  • [3] Transfusional Iron Overload and Iron Chelation Therapy in Thalassemia Major and Sickle Cell Disease
    Marsella, Maria
    Borgna-Pignatti, Caterina
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2014, 28 (04) : 703 - +
  • [4] Iron chelation therapy in thalassemia major
    Guven, sirin
    Erdogan, Makbule
    MEDICAL JOURNAL OF BAKIRKOY, 2007, 3 (04) : 125 - 129
  • [5] Serum Hepcidin as a Diagnostic Marker of Severe Iron Overload in Beta-thalassemia Major
    Kaddah, Ahmed Maher
    Abdel-Salam, Amina
    Farhan, Marwa Salah
    Ragab, Reham
    INDIAN JOURNAL OF PEDIATRICS, 2017, 84 (10): : 745 - 750
  • [6] Serum Hepcidin as a Diagnostic Marker of Severe Iron Overload in Beta-thalassemia Major
    Ahmed Maher Kaddah
    Amina Abdel-Salam
    Marwa Salah Farhan
    Reham Ragab
    The Indian Journal of Pediatrics, 2017, 84 : 745 - 750
  • [7] Hepcidin gene polymorphisms and iron overload in β-thalassemia major patients refractory to iron chelating therapy
    Zarghamian, Parinaz
    Azarkeivan, Azita
    Arabkhazaeli, Ali
    Mardani, Ahmad
    Shahabi, Majid
    BMC MEDICAL GENETICS, 2020, 21 (01)
  • [8] Longitudinal Changes in Iron Overload Parameters and Iron Chelation Therapy in Young Patients with Thalassemia Major
    Kattamis, Antonis
    Stokidis, Konstantinos
    Delaporta, Polyxeni
    Dimitra, Kyriakopoulou
    Petropoulou, Theoni
    Boiu, Sorina
    Ladis, Vassilis
    BLOOD, 2011, 118 (21) : 1383 - 1383
  • [9] Serum Metabolite Profiles Are Reflective of Iron Overload in Thalassemia Major Patients on Chelation Therapy
    Sayani, Farzana
    Abdolmohammadi, Niloufar
    Lauf, Anne Marie
    Weljie, Aalim
    BLOOD, 2011, 118 (21) : 925 - 925
  • [10] Serum Hepcidin as a Diagnostic Marker of Severe Iron Overload in Beta-thalassemia Major: Correspondence
    The Indian Journal of Pediatrics, 2017, 84 (12) : 967 - 968
12345